Internal Medicine, Rheumatology · Los Angeles, CA
NPI
1275614455
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
520 S Virgil Ave Ste 300
Los Angeles, CA, 90020
Phone (213) 736-0080
Groups this clinician bills Medicare through
Medicare paid, 2024
$337K
19,961 services
Medicare patients, 2024
736
Average age 79
Drug cost, 2024
$6.2M
7,106 prescriptions
Company payments, 2025
$2,585
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian N Huh was code J1010 (injection, methylprednisolone acetate, 1 mg), 8,565 times for 135 patients. In total Brian N Huh billed 19,961 services in 28 codes, and Medicare paid $337K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 8,565 | 135 | $0.10 | $877 |
| J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2,438 | 14 | $0.39 | $939 |
| J0897 Injection, denosumab, 1 mg | Office | 2,400 | 25 | $19.76 | $47K |
| 99213 Office E&M - Established | Office | 1,235 | 556 | $69.92 | $86K |
| J7323 Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 733 | 137 | $93.45 | $69K |
| 20610 Joint Injection | Office | 663 | 182 | $66.53 | $44K |
| 96372 Injection Administration | Office | 463 | 209 | $10.29 | $4,765 |
| 99212 Office E&M - Established | Office | 345 | 147 | $52.25 | $18K |
| 99203 Office E&M - New | Office | 194 | 194 | $85.77 | $17K |
| 77080 Standard X-ray | Office | 164 | 164 | $47.73 | $7,827 |
| 99214 Office E&M - Established | Office | 148 | 124 | $100.50 | $15K |
| 36415 Venipuncture Blood Collection | Office | 85 | 65 | $8.65 | $735 |
| 20550 Musculoskeletal | Office | 49 | 43 | $53.98 | $2,645 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 30 | 23 | $3.36 | $101 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 26 | 26 | $2.97 | $77.21 |
By year: 2022 $405K for 14,895 services; 2023 $328K for 9,471 services; 2024 $337K for 19,961 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 85 | 65 | $8.65 | $735 |
Medicare prescription drug claims, 2024
In 2024, the drug Brian N Huh prescribed most often to Medicare patients was Celecoxib, with 939 prescriptions and refills. In total Brian N Huh wrote 7,106 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Celecoxib Generic | 939 | 1,166 | 330 | $19K |
| Hydroxychloroquine Sulfate Generic | 616 | 1,215 | 152 | $15K |
| Methotrexate Methotrexate Sodium | 538 | 1,182 | 143 | $12K |
| Meloxicam Generic | 530 | 720 | 235 | $1,270 |
| Prolia Denosumab | 421 | 2,523 | 249 | $689K |
| Rinvoq Upadacitinib | 313 | 313 | 35 | $1.9M |
| Alendronate Sodium Generic | 240 | 569 | 68 | $981 |
| Baclofen Generic | 239 | 304 | 93 | $708 |
| Pantoprazole Sodium Generic | 222 | 328 | 111 | $1,224 |
| Lidocaine Generic | 175 | 185 | 37 | $38K |
| Duloxetine Hcl Generic | 172 | 296 | 60 | $1,932 |
| Prednisone Generic | 172 | 279 | 48 | $1,591 |
| Methylprednisolone Generic | 164 | 170 | 117 | $1,001 |
| Xeljanz Xr Tofacitinib Citrate | 112 | 112 | 12 | $622K |
| Enbrel Sureclick Etanercept | 109 | 109 | 14 | $795K |
Brand drugs: - claims; generic drugs: 5,555 claims; opioid claims: 161.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian N Huh $2,585 ($2,585 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $839.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 39 | $839 |
| Amgen Inc. AMGN | 28 | $654 |
| UCB, Inc. UCB.BR | 13 | $373 |
| Pfizer Inc. PFE | 12 | $321 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $121 |
| GlaxoSmithKline, LLC. GSK | 4 | $90.67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $73.16 |
| Janssen Biotech, Inc. JNJ | 2 | $63.88 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Genzyme Corporation SNY | 1 | $25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.